Be more like denmark - pharma-innovation trip to Copenhagen

My Learnings from Our Pharma & Life Science Innovation Trip to Copenhagen

Denmark has three to four major industries (besides Lego ) in which it is (almost always) a global leader:

1.  Logistics (Maersk and DSV)
2.  Wind Energy (Vestas)
3.  Pharmaceuticals (Novo Nordisk)

1.  Long-Term Thinking and Investment

The major Danish pharmaceutical companies (including Novo Nordisk, Lundbeck, Leo Pharma) are backed by foundations. These foundations have statutes that mandate:

• Staying in Denmark and reinvesting locally
• Prioritizing long-term thinking (no pressure from shareholders)

This setup fosters stability and growth in the national ecosystem.

2. Strategic Focus of the Country

Denmark deliberately concentrates on a few key sectors (see above: Pharma & Life Science, Wind Energy, Logistics). Why: With only 6 million inhabitants, the country focuses intentionally on clusters with proven success models.

This leads to:

• Universities serving the needs of industry
• Close collaboration between academia and the private sector
• Targeted training for future talent in those clusters
• Strong investment in fundamental research, especially in pharma

3. Culture of Trust

Danes trust each other and their institutions – for example, there are no health insurance companies. Everything runs through a centralized, state-funded system.

Denmark has had a national health data strategy for 40 years. All health data since 2003 is stored on a central digital government server (Germany started in April 2025). These data can be used for research purposes by Danish pharmaceutical companies – but only with the individual user’s consent.

Work culture is also shaped by high levels of trust:

• Flexible working hours & modern practices
• Flat hierarchies, consensus-based decisions, and direct communication with leadership
• Downside: Sometimes too much consensus culture leads to slow decision-making

4. (Clinical) Trial Nation & Scaling

Denmark offers a coordinated system to develop pharmaceutical innovations from basic research to globally scaled products.

With Trial Nation (a state-supported platform), the country enables clinical studies and early-stage production.

For every phase – from idea to clinical validation to mass production – Denmark provides the right infrastructure. This allows faster translation from research to market-ready products and turns strong ideas into global pharma successes.

We’re planning the next trip in 2026.

If you’re interested in joining us – feel free to reach out!